Medindia LOGIN REGISTER
Medindia

Indian Drugmaker Marion Biotech Halts Manufacture of Cough Syrup

by Colleen Fleiss on Dec 30 2022 11:45 PM
Listen to this article
0:00/0:00

Indian Drugmaker Marion Biotech Halts Manufacture of Cough Syrup
Marion Biotech, the Indian Pharma company had stopped the production of cough syrup following allegations by Uzbekistan that at least 18 children died in the country after consuming the medicine.
A joint inspection of the manufacturer's Noida facility was carried out by the teams of the Uttar Pradesh Drug Control Department and CDSCO.

The Central Drugs Standard Control Organization (CDSCO) is in contact with the national drug regulator of Uzbekistan regarding the matter.

Cough Syrup Linked to Children Deaths

"Immediately on receipt of the information, joint inspection of the NOIDA facility of the manufacturer, Marion Biotech, was carried out by UP Drug Control and CDSCO team and further action as appropriate would be initiated based on the inspection report," said the Union health ministry on Thursday.

The samples of the cough syrup have been taken from the manufacturing premises and sent to Regional Drugs Testing Laboratory (RDTL), Chandigarh for testing.

Meanwhile, Marion Biotech Pharma company has said that it has sent samples of the said cough syrup for testing and has also halted the production of the product.

Hasan, the Legal Head of Marion Biotech, expressed grief over the deaths on behalf of the company and said that an inquiry in the matter was being conducted by the government.

He added that samples were collected and action would be taken on the basis of the report.

Advertisement
Uzbekistan's health ministry, on Tuesday, December 27, 2022, said that 18 children suffering from an acute respiratory disease died after taking excessive doses of cough syrup Dok 1 Max, manufactured by Marion Biotech.

Source-IANS


Advertisement